Lawmakers propose bill to loosen FDA panel rules. Spearheaded by Sen. Amy Klobuchar of Minnesota, the Medical Device Regulatory Improvement Act hit the Senate floor on Thursday. The bill aims to ease strict conflict of interest rules for FDA advisers, which make it sometimes difficult to find experts to serve on panels, thus slowing down the approval process. A similar bill is expected to be introduced today in the House.